Gerald M. Lieberman is Director at Entera Bio Ltd. (ENTX). They have made 5 open-market trades across 1 company since 2022, most recently 2026-06-05.
CIK 0001234346
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
5 open-market purchases totalling $91K since 2022, never a sale. Across 5 scored buys the stock is up 29.9% at ninety days, and 27.9 points ahead of the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 40% | 40% | 60% |
| Avg Move | +2.4% | -1.0% | +29.9% |
| Alpha | +0.7% | -0.9% | +27.9% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ENTX | BUY | 2023-12-22 | 2023-12-27 | $0.71 | $17K | +20.6% | +38.1% | +145.9% |
| ENTX | BUY | 2023-08-21 | 2023-08-23 | $0.59 | $12K | -12.5% | -5.7% | -3.1% |
| ENTX | BUY | 2022-11-14 | 2022-11-15 | $0.57 | $24K | +8.7% | +0.2% | +43.8% |
| ENTX | BUY | 2022-07-21 | 2022-07-25 | $1.68 | $33K | -4.9% | -23.9% | -59.6% |
| ENTX | BUY | 2022-01-18 | 2022-01-24 | $2.80 | $6K | +0.0% | -13.5% | +22.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.